Save time and get answers to complex questions with AI chat
Complera manufacturer?Pramlintide fda approval date?When will generic fiasap insulin be available?When is the expected fda decision date for apotex's ruxolitinib resubmission?Does lipitor's effectiveness decrease with high fat meals?
See the DrugPatentWatch profile for Incruse
Incruse Ellipta contains: - Active ingredient: umeclidinium bromide (55 mcg per inhalation) - Inactive ingredient (excipient): lactose monohydrate (used as a carrier in the powder) The inhaler is a dry-powder inhaler (Ellipta) and the listed drug ingredients are umeclidinium bromide and lactose monohydrate. If you have a dairy allergy or lactose intolerance, or need the exact ingredient list for allergies, check the patient information leaflet or talk to a pharmacist/doctor.
Other Questions About Incruse :